We then determined whether GZ17-6.02 interacted with pemetrexed to kill other NSCLC cell lines, regardless of mutant RAS or ERBB1 expression; GZ17-6.02 and pemetrexed interacted to kill (Figure 2C). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.